AHA 2009 schedule: Difference between revisions
Jump to navigation
Jump to search
| (30 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
Here is the page we will use to coordinate interviews at AHA 2009 | Here is the page we will use to coordinate interviews at AHA 2009 | ||
'''Filming location:''' | '''Filming location:''' Hilton Orlando 6001 Destination Parkway Orlando, FL 32819 | ||
Filming will occur from Saturday to Tuesday (November 14 - November 17). Dr. Gibson is available to interview during all times listed '''in black'''. For all times listed '''<font color="green"> in green</font>''', Dr. Gibson is unavailable to conduct the interview. You may, however, go ahead and speak about your topic/present your slides. | Filming will occur from Saturday to Tuesday (November 14 - November 17). Dr. Gibson is available to interview during all times listed '''in black'''. For all times listed '''<font color="green"> in green</font>''', Dr. Gibson is unavailable to conduct the interview. You may, however, go ahead and speak about your topic/present your slides. | ||
| Line 25: | Line 25: | ||
===9:00 AM=== | ===9:00 AM=== | ||
*'''Interviewee:''' | *'''Interviewee:''' Gennaro Sardella | ||
*'''Trial:''' Impact of Thrombectomy with EXPort Catheter in Infarct Related Artery during Primary PCI on Procedural Outcome in Patients with AMI (EXPIRA Trial). 24 Months Clinical Outcome | *'''Trial:''' Impact of Thrombectomy with EXPort Catheter in Infarct Related Artery during Primary PCI on Procedural Outcome in Patients with AMI (EXPIRA Trial). 24 Months Clinical Outcome | ||
| Line 31: | Line 31: | ||
===10:00 AM=== | ===10:00 AM=== | ||
*'''Interviewee:''' Philippe Gabriel Steg | |||
*'''Trial:''' PLATO Trial | |||
===10:30 AM=== | ===10:30 AM=== | ||
*'''Interviewee:''' Jeanne E. Poole | |||
*'''Trial:''' Complications Associated with Planned Pacemaker or Defibrillator Lead Addition at the Time of Generator Change: Results from the REPLACE Registry | |||
===11:00 AM=== | ===11:00 AM=== | ||
| Line 38: | Line 42: | ||
===11:30 AM=== | ===11:30 AM=== | ||
===12:00 PM=== | === <font color="green">12:00 PM</font>=== | ||
===12:30 PM=== | === <font color="green">12:30 PM</font>=== | ||
===1:00 PM=== | === <font color="green">1:00 PM</font>=== | ||
===1:30 PM=== | === <font color="green">1:30 PM</font>=== | ||
===2:00 PM=== | ===2:00 PM=== | ||
| Line 63: | Line 67: | ||
==Sunday November 15, 2009== | ==Sunday November 15, 2009== | ||
===8:30 AM=== | === <font color="green">8:30 AM</font>=== | ||
===9:00 AM=== | === <font color="green">9:00 AM</font>=== | ||
===9:30 AM=== | === <font color="green">9:30 AM</font>=== | ||
===10:00 AM=== | === <font color="green">10:00 AM</font>=== | ||
===10:30 AM=== | === <font color="green">10:30 AM</font>=== | ||
===11:00 AM=== | === <font color="green">11:00 AM</font>=== | ||
===11:30 AM=== | === <font color="green">11:30 AM</font>=== | ||
===12:00 PM=== | === <font color="green">12:00 PM</font>=== | ||
===12:30 PM=== | === <font color="green">12:30 PM</font>=== | ||
===1:00 PM=== | ===1:00 PM=== | ||
===1:30 PM=== | ===1:30 PM=== | ||
*'''Interviewee:''' Maria Brooks | |||
*'''Trial:''' Quality of Life Results in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial | |||
===2:00 PM=== | ===2:00 PM=== | ||
*'''Interviewee:''' Bernard Chaitman | |||
*'''Trial:''' Prompt Coronary Revascularization Reduces Non-Fatal Myocardial Infarction in Patients with Type II Diabetes and More Extensive Vascular Disease: Results from BARI2D | |||
=== <font color="green">2:30 PM</font>=== | === <font color="green">2:30 PM</font>=== | ||
| Line 93: | Line 101: | ||
=== <font color="green">3:30 PM</font>=== | === <font color="green">3:30 PM</font>=== | ||
===4:00 PM=== | === <font color="green">4:00 PM</font>=== | ||
=== <font color="green">4:30 PM</font>=== | |||
| Line 111: | Line 119: | ||
===10:00 AM=== | ===10:00 AM=== | ||
*'''Interviewee:''' Christian Hamm | |||
*'''Trial:''' PEPCAD III: A Randomized Trial Comparing a Paclitaxel-Coated Balloon/Stent System with a Sirolimus Eluting Stent | |||
===10:30 AM=== | ===10:30 AM=== | ||
*'''Interviewee:''' Cheuk-Man Yu | |||
*'''Trial:''' Results of the Pacing to Avoid Cardiac Enlargement (PACE) Trial | |||
===11:00 AM=== | ===11:00 AM=== | ||
*'''Interviewee:''' Bruce Rollman | |||
*'''Trial:''' Telephone-Delivered Collaborative Care for Treating Post-CABG Depression: 8-Month Outcomes from The Bypassing The Blues Trial | |||
===11:30 AM=== | ===11:30 AM=== | ||
*'''Interviewee:''' Stefan Anker | |||
*'''Trial:''' Ferric Carboxymaltose Assessment in Patients with Iron Deficiency and Chronic Heart Failure With and Without Anemia (FAIR-HF): A Randomized, Double-blind, Placebo-controlled, International Multi-center Phase III Study | |||
===12:00 PM=== | ===12:00 PM=== | ||
*'''Interviewee:''' Philippe Meurin | |||
*'''Trial:''' Non-Steroidal Anti-Inflammatory Treatment for Post-operative Pericardial Effusion: The POPE Study, A Multicenter, Double-blind, Randomized Trial | |||
=== <font color="green">12:30 PM</font>=== | === <font color="green">12:30 PM</font>=== | ||
| Line 124: | Line 142: | ||
=== <font color="green">1:00 PM</font>=== | === <font color="green">1:00 PM</font>=== | ||
===1:30 PM=== | === <font color="green">1:30 PM</font>=== | ||
===2:00 PM=== | === <font color="green">2:00 PM</font>=== | ||
===2:30 PM=== | === <font color="green">2:30 PM</font>=== | ||
=== <font color="green">3:00 PM</font>=== | === <font color="green">3:00 PM</font>=== | ||
| Line 145: | Line 163: | ||
===8:30 AM=== | ===8:30 AM=== | ||
===9:00 AM=== | === <font color="green">9:00 AM</font>=== | ||
=== <font color="green">9:30 AM</font>=== | === <font color="green">9:30 AM</font>=== | ||
| Line 154: | Line 172: | ||
===10:45 AM=== | ===10:45 AM=== | ||
*'''Interviewee:''' Deepak Bhatt | |||
*'''Trial:''' CHAMPION PLATFORM Trial | |||
===11: | ===11:15 AM=== | ||
*'''Interviewee:''' Robert Harrington | |||
*'''Trial:''' CHAMPION PCI Trial | |||
===11: | ===11:45 AM=== | ||
*'''Interviewee:''' John Camm | |||
*'''Trial:''' Differences in Clinical Outcomes with Rhythm-and Rate-control Therapies for Atrial Fibrillation in the RecordAF Registry | |||
===12:00 PM=== | ===12:00 PM=== | ||
| Line 178: | Line 202: | ||
===4:30 PM=== | ===4:30 PM=== | ||
*'''Interviewee:''' Marvin Konstam | |||
*'''Trial:''' Comparison of Low-Dose Versus High-Dose Losartan Treatment on Morbidity and Mortality in Angiotensin Converting Enzyme Inhibitor-Intolerant Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction: Results of the HEAAL Study | |||
''[[AHA 2009 schedule#Click on Date for Detailed Schedule|Return to top]]'' | ''[[AHA 2009 schedule#Click on Date for Detailed Schedule|Return to top]]'' | ||
Latest revision as of 19:24, 10 November 2009
Here is the page we will use to coordinate interviews at AHA 2009
Filming location: Hilton Orlando 6001 Destination Parkway Orlando, FL 32819
Filming will occur from Saturday to Tuesday (November 14 - November 17). Dr. Gibson is available to interview during all times listed in black. For all times listed in green, Dr. Gibson is unavailable to conduct the interview. You may, however, go ahead and speak about your topic/present your slides.
Click on Date for Detailed Schedule
Saturday, November 14, 2009
8:30 AM
9:00 AM
- Interviewee: Gennaro Sardella
- Trial: Impact of Thrombectomy with EXPort Catheter in Infarct Related Artery during Primary PCI on Procedural Outcome in Patients with AMI (EXPIRA Trial). 24 Months Clinical Outcome
9:30 AM
10:00 AM
- Interviewee: Philippe Gabriel Steg
- Trial: PLATO Trial
10:30 AM
- Interviewee: Jeanne E. Poole
- Trial: Complications Associated with Planned Pacemaker or Defibrillator Lead Addition at the Time of Generator Change: Results from the REPLACE Registry
11:00 AM
11:30 AM
12:00 PM
12:30 PM
1:00 PM
1:30 PM
2:00 PM
2:30 PM
3:00 PM
3:30 PM
4:00 PM
4:30 PM
Sunday November 15, 2009
8:30 AM
9:00 AM
9:30 AM
10:00 AM
10:30 AM
11:00 AM
11:30 AM
12:00 PM
12:30 PM
1:00 PM
1:30 PM
- Interviewee: Maria Brooks
- Trial: Quality of Life Results in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
2:00 PM
- Interviewee: Bernard Chaitman
- Trial: Prompt Coronary Revascularization Reduces Non-Fatal Myocardial Infarction in Patients with Type II Diabetes and More Extensive Vascular Disease: Results from BARI2D
2:30 PM
3:00 PM
3:30 PM
4:00 PM
4:30 PM
Monday November 16, 2009
8:30 AM
9:00 AM
9:30 AM
10:00 AM
- Interviewee: Christian Hamm
- Trial: PEPCAD III: A Randomized Trial Comparing a Paclitaxel-Coated Balloon/Stent System with a Sirolimus Eluting Stent
10:30 AM
- Interviewee: Cheuk-Man Yu
- Trial: Results of the Pacing to Avoid Cardiac Enlargement (PACE) Trial
11:00 AM
- Interviewee: Bruce Rollman
- Trial: Telephone-Delivered Collaborative Care for Treating Post-CABG Depression: 8-Month Outcomes from The Bypassing The Blues Trial
11:30 AM
- Interviewee: Stefan Anker
- Trial: Ferric Carboxymaltose Assessment in Patients with Iron Deficiency and Chronic Heart Failure With and Without Anemia (FAIR-HF): A Randomized, Double-blind, Placebo-controlled, International Multi-center Phase III Study
12:00 PM
- Interviewee: Philippe Meurin
- Trial: Non-Steroidal Anti-Inflammatory Treatment for Post-operative Pericardial Effusion: The POPE Study, A Multicenter, Double-blind, Randomized Trial
12:30 PM
1:00 PM
1:30 PM
2:00 PM
2:30 PM
3:00 PM
3:30 PM
4:00 PM
4:30 PM
Tuesday November 17, 2009
8:30 AM
9:00 AM
9:30 AM
10:00 AM
10:30 AM
10:45 AM
- Interviewee: Deepak Bhatt
- Trial: CHAMPION PLATFORM Trial
11:15 AM
- Interviewee: Robert Harrington
- Trial: CHAMPION PCI Trial
11:45 AM
- Interviewee: John Camm
- Trial: Differences in Clinical Outcomes with Rhythm-and Rate-control Therapies for Atrial Fibrillation in the RecordAF Registry
12:00 PM
12:30 PM
1:00 PM
1:30 PM
2:00 PM
2:30 PM
3:00 PM
3:30 PM
4:00 PM
4:30 PM
- Interviewee: Marvin Konstam
- Trial: Comparison of Low-Dose Versus High-Dose Losartan Treatment on Morbidity and Mortality in Angiotensin Converting Enzyme Inhibitor-Intolerant Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction: Results of the HEAAL Study